Provivi is a Biotech company based in Santa Monica. It has raised $260M in total funding. Latest round: Growth.
Provivi funding overview
Provivi is a Biotech company based in Santa Monica. Provivi has raised $260M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in April 2026. The round record for Provivi runs through 2026; nothing later has been disclosed. Investors on record include MLS Capital, BASF Venture Capital, Kairos Ventures, Pontifax Agtech, Tybourne Capital Management, The Bill & Melinda Gates Foundation Trust and 4 others. 10 distinct backers are named across the disclosed rounds.
Provivi at a glance
Total raised
$260M
Latest round
Growth
Latest round date
April 2026
Industry
Biotech
Headquarters
Santa Monica
Notable investors
MLS Capital, BASF Venture Capital, Kairos Ventures, Pontifax Agtech, Tybourne Capital Management, The Bill & Melinda Gates Foundation Trust, Temasek, Xeraya Capital
Frequently asked about Provivi funding
How much has Provivi raised?
Provivi has raised $260M in total disclosed funding across the rounds on record.
Who has invested in Provivi?
MLS Capital, BASF Venture Capital, Kairos Ventures, Pontifax Agtech, Tybourne Capital Management, The Bill & Melinda Gates Foundation Trust are named among the investors backing Provivi.
What was the latest Provivi funding round?
The most recent disclosed round is a Growth, announced in April 2026.
Where is Provivi based?
Provivi is based in Santa Monica.
What sector does Provivi operate in?
Provivi is tracked under Biotech from Santa Monica, with $260M in disclosed funding.
When did Provivi last raise?
The last disclosed Provivi round closed in April 2026 at Growth.
Every Provivi figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Santa Monica at a similar stage.
